News

Oct 31
Actinium’s stock jumps 22% on new data for its acute myeloid leukemia therapy

Shares of Actinium Pharmaceuticals Inc. ATNM, +30.82% were up 22.8% in trading on Monday after the company met the primary endpoint in a Phase 3 clinical trial for its investigational treatment for relapsed or refractory acute myeloid leukemia. Actinium said it plans to share additional clinical data by the end of the year. The company’s […]

Oct 31
The cryptocurrency market digest (BTC, DOGE). Overview for 31.10.2022

The leading cryptocurrency is creeping down again. On Monday, main fluctuations are near 20,487 USD. To preserve the uptrend in force, the BTC needs to brace itself and secure above 21,500 USD. Until this happens, all movements will be inside a flat. The most important event of this week and month is coming, and this […]

Oct 31
Japanese Candlesticks Analysis 31.10.2022 (XAUUSD, NZDUSD, GBPUSD)

XAUUSD, “Gold vs US Dollar” At the support level, gold has formed a Harami reversal pattern. Currently, the pair may go by the signal in a wave of correction. The goal of growth will be 1660.50. Upon testing the resistance level, the pair may bounce off it and continue the downtrend. However, the quotes may […]

Oct 31
EU crypto sanctions against Russia have an unexpected enforcer

The Monetary Authority of Singapore says crypto exchanges in the country must comply with financial sanctions against Russia. 1300 Total views 18 Total shares The Monetary Exchange of Singapore (MAS), ​​the country’s central bank and financial regulator, reminded all authorized cryptocurrency exchanges in the country to comply with financial sanctions in place against Russia.  The […]

Oct 31
J&J suspends enrollment in clinical trial assessing Essa Pharma’s prostate cancer treatment

Shares of Essa Pharma Inc. EPIX, -24.72% fell 28.6% in premarket trading on Monday after the company said Johnson & Johnson JNJ, -0.54% suspended enrollment in a Phase 1 clinical trial for Essa’s experimental prostate cancer therapy, citing patient recruitment challenges. Essa had announced a clinical collaboration with J&J back in 2021. “We are in […]

Oct 31
Instil Bio’s stock falls 35% after disclosing the cell therapy company paused enrollment in clinical trials

Shares of Instil Bio Inc. TIL, -29.24% tumbled 35.1% in premarket trading on Monday after the company said it paused enrollment in clinical trials for two experimental cell therapies due to manufacturing issues. Instil said it had notified regulators, and the decision is not the result of a clinical hold. “This pause in enrollment provides […]